Safety and Tolerability of a 'Refrigeration-free' Formulation of Interferon Beta-1b – Results of a Double-blind, Multicentre, Comparative Study in Patients with Relapsing–Remitting or Secondary Progressive Multiple Sclerosis

By Baum K    

The Journal of International Medical Research, Vol. 34, Iss. 1, 2006-01 ,pp. : 1-12

Field House Publishing

Access to resources Recommend Favorite

High-dose, high-frequency recombinant interferon beta-1a in the treatment of multiple sclerosis

By Hartung Hans-Peter  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 2, 2009-02 ,pp. : 291-309

Informa Healthcare

Access to resources Recommend Favorite

Dose and Frequency of Administration of Interferon- Affect its Efficacy in Multiple Sclerosis

By Sharief M.K.  

Clinical Drug Investigation, Vol. 23, Iss. 9, 2003-01 ,pp. : 551-559

Adis International

Access to resources Recommend Favorite

Interferon-β_1b for the treatment of multiple sclerosis

By Lam Sum   Wang Shan   Gottesman Malcolm  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 8, 2008-08 ,pp. : 1111-1117

Informa Healthcare

Access to resources Recommend Favorite

Interferon-β_1b in the treatment of multiple sclerosis

By Río Jordi   Montalban Xavier  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 16, 2005-12 ,pp. : 2877-2886

Informa Healthcare

Access to resources Recommend Favorite